Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Smoking Cessation
- Tobacco Use Disorder
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 21 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04868253
- Collaborators
- Foundation for a Smoke-Free World
- Embera NeuroTherapeutics, Inc.
- Investigators
- Not Provided
Get Well Soon